Evidence map›Paper›PMID 34391389›Full record

ArticleBMC public health2021

Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.

Francis O Oguya, Patrick R Kenya, Francisca Ongecha, Patrick Mureithi, Helgar Musyoka, Nicholas Muraguri, Ben Mundia, Caleb Angira, Mohammed Shose, Taib A Basheeb and 6 more

Abstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francis O OguyaDepartment of Health Systems Management and Public Health, Technical University of Kenya, Nairobi, Kenya. foguya@tukenya.ac.ke.
Patrick R KenyaInternational Centre for Health Interventions Research in Africa (ICHIRA), Nairobi, Kenya.
Francisca OngechaInternational Centre for Health Interventions Research in Africa (ICHIRA), Nairobi, Kenya.
Patrick MureithiNational AIDS Control Council (NACC), Nairobi, Kenya.
Helgar MusyokaNational AIDS and STDs Control Programme (NASCOP), Nairobi, Kenya.
Nicholas MuraguriNational AIDS and STDs Control Programme (NASCOP), Nairobi, Kenya.
Ben MundiaNational AIDS Control Council (NACC), Nairobi, Kenya.
Caleb AngiraNairobi Outreach Services Trust (NOSET), Nairobi, Kenya.
Mohammed ShoseOMARI Malindi, Nairobi, Kenya.
Taib A BasheebReachout Centre Trust, Nairobi, Kenya.
Abdalla Ahmed MohamedMuslim Education Welfare Association (MEWA), Nairobi, Kenya.
John P OyoreSchool of Public Health, Kenyatta University, Nairobi, Kenya.
Otieno G OchiengSchool of Public Health, Kenyatta University, Nairobi, Kenya.
Gabriel O DidaDepartment of Health Systems Management and Public Health, Technical University of Kenya, Nairobi, Kenya. gdidah@gmail.com.ORCID 0000-0003-2442-0352
Saade AbdallaUnited Nations Office Drugs Crime (UNODC-ROEA), Nairobi, Kenya.
Reychard AbdoolUnited Nations Office Drugs Crime (UNODC-ROEA), Nairobi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA Cross-sectional Rapid Situational Assessment of People Who Inject Drug (PWIDs) applying Respondent Driven sampling techniques (RDS) was used to recruit subjects/participants in a study aimed at assessing HIV prevalence and risk behaviors among injecting drug users in Nairobi and Coastal regions of Kenya. There is paucity of data and information on injecting drug use in sub-Saharan Africa and there is sufficient evidence of existence of the environment for development and growth of injecting drug use. Past studies on PWID and its association to HIV and AIDS that have been conducted in Kenya do not provide sufficient information to support effective planning and comprehensive national response to the HIV and AIDS epidemic.

methodsA cross-sectional study design was adopted in which a set of initial subjects referred to as 'seeds' were first identified from which an expanding chain of referrals were obtained, with subjects from each wave referring subjects of subsequent waves. The seeds were drawn randomly from the population and interviewed to pick the one with the largest network and other unique characteristics. A maximum of twelve seeds were recruited. The second stage involved conducting assessment visits to the sites to identify potential collaborators that included non-governmental organizations (NGOs), drug treatment centres, health facilities, community based organizations (CBO's) among others. Three NGOs located in the coast region and one in Nairobi region were identified to assist in identifying drug injection locations and potential participants. Key informant interviews (KIIs) and Focus Group Discussions (FGDs) were also conducted using interview guides.

resultsA total of 646 individuals (344 in Nairobi and 302 at the coast) were recruited for the study between January and March 2010. Of these 590 (91%) were male and 56 (9%) were female. Findings showed that most PWIDs initiated injecting drug use between the ages of 20-29 years, with the youngest age of initiation being 11 years and oldest age being 53 years. Most commonly injected drug was heroin (98%), with a small (2%) percentage injecting cocaine. Other non-injecting methods such as smoking or combining these two drugs with other drugs such as cannabis or Rohypnol were also common. Most PWIDs used other substances (cigarettes, alcohol, and cannabis) before initiating injecting drug use. The adjusted national HIV prevalence of PWIDs was 18.3% (19.62% unadjusted) with PWIDs in Nairobi region registering 18.33% (20.58% unadjusted) compared PWIDs for Coastal region indicating 18.27% (18.59% - unadjusted). The gender based HIV prevalence showed that women were more at risk of acquiring HIV (44.51%-adjusted) compared to men (15.97%-adjusted). The age specific HIV prevalence showed that PWIDs who initiated injecting at 11-19 years (44.7% adjusted) were most at risk in Nairobi compared to those who initiated injecting at age 20-24 years (23.2% - adjusted) in the coastal region. While all PWIDs continue to be at risk in the two regions, those from the Western parts of Nairobi, Kenya were at a relatively higher risk given their increased propensity for sharing injecting equipment and solutions.

conclusionsCompared to the national HIV prevalence of (4.9%), the results show that People Who Inject Drugs (PWIDs) are at particularly high risk of infection in Kenya and there is urgent need for intervention (KenPHIA, 2018). This study also showed clear evidence that 70% of PWIDs are primary school educated, engage in high risk injecting and sexual behaviors comprising sharing of injecting equipment, unprotected heterosexual and homosexual sex. Given that initiation of injecting drug use begins early and peaks after formal school years (20-29 years), prevention programmes should be targeted at primary and secondary school students, college and out of school youth. Further, to protect People who inject drugs (PWIDs) from HIV infection, the country should introduce free Needle Syringe Programs (NSP) with provision of condoms and Methadone Assisted Therapy (MAT) as a substitute for drug use.

Indexed as

HIV InfectionsPharmaceutical PreparationsSubstance Abuse, IntravenousAdolescentAdultCross-Sectional StudiesFemaleHumansKenyaMalePrevalenceRisk-TakingSurveys and QuestionnairesYoung AdultPharmaceutical PreparationsHIV-related behaviorsInjection drug users (PWIDs)KenyaMombasaNairobiRespondent driven sampling

Identifiers

PMID34391389
PMCPMC8364050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.